The Vanguard Group Report on Spire Healthcare Group plc Stake

The Vanguard Group, Inc. has disclosed its position in Spire Healthcare Group plc through a Form 8.3 filing, as required by Rule 8.3 of the Takeover Code. The disclosure, dated October 16, 2026, details Vanguard's interest in Spire Healthcare's securities, significant as it represents holdings of 1% or more. As of October 15, 2026, Vanguard controls 3.59% of Spire's ordinary shares, totaling 14,439,832 shares.

The filing also notes that Vanguard engaged in a sale of 1,096 ordinary shares at 2.48 GBP per unit. No agreements or derivatives are influencing Vanguard's voting rights or the future acquisition of related securities. No additional forms, such as a Supplemental Form 8, were included in the disclosure.